Official: FDA Assessing EU Drug Regime, But TTIP Won't Affect Outcome

A senior U.S. Food & Drug Administration (FDA) official has said the agency is actively assessing whether it can rely more on European Union regulators in inspecting the manufacturing practices of EU pharmaceutical firms, but made clear that the timeline and ultimate result of these efforts will not be influenced by the broader U.S.-EU trade talks. Mark Abdoo, director of the Office of Public Health and Trade in FDA's Office of International Programs and the lead FDA representative to the...